PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
申请人:Arora Nidhi
公开号:US20120015962A1
公开(公告)日:2012-01-19
Compounds of the formula I or II:
wherein X, m, Ar, R
1
and R
2
are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
[EN] INHIBITORS OF EZH2<br/>[FR] INHIBITEURS DE L'EZH2
申请人:LILLY CO ELI
公开号:WO2017035060A1
公开(公告)日:2017-03-02
The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.
本发明涉及抑制组蛋白赖氨酸甲基转移酶Enhancer of Zeste Homolog 2(EZH2)活性的化合物,包括这些化合物的药物组合物,以及使用这些化合物治疗癌症,如血液学和实体肿瘤的方法。
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
申请人:Novartis AG
公开号:US20200017461A1
公开(公告)日:2020-01-16
The present disclosure provides a compound of Formula (I′):
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R
x
, X
1
, X
2
, and R
1
are as defined herein, and methods of making and using same.
A glycerin derivative having the following formula (I) or (I') and a pharmacologically acceptable salt thereof are useful to treat diseases caused by the platelet activating factor. ##STR1##